Proof of Usefulness Report

MimiVax

Analysis completed on 1/25/2026

+62
Proof of Usefulness Score
You're In Business

MimiVax is a legitimate clinical-stage biotechnology company developing SurVaxM, a promising immunotherapy for glioblastoma with FDA Fast Track designation and positive Phase 2b data. However, the project submission contains significant factual errors (listing 'energy-solutions' as technology) and false claims regarding traction ('most people have used my product'). While the scientific utility and innovation are exceptionally high, the score is heavily penalized by the lack of commercial availability (pre-market) and the poor quality/inaccuracy of the submission data.

Ready to Compete for $150k+ in Prizes?

Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes

View All Reports

Score Breakdown

Real World Utility+23.75
Audience Reach Impact+4.00
Technical Innovation+13.50
Evidence Of Traction+7.50
Market Timing Relevance+9.00
Functional Completeness+0.25
Subtotal+58
Usefulness Multiplierx1.07
Final Score+62

Project Details

Project URL
mimivax.com
Description
MimiVax is a biotechnology company focused on the development of innovative immunotherapeutic products for the treatment of cancer. Leveraging cutting-edge research and technology, MimiVax aims to harness the power of the immune system to target and eliminate cancer cells. The company is dedicated to advancing its pipeline of novel therapies, with a commitment to improving patient outcomes and providing new hope for those affected by cancer. Through strategic collaborations and a robust research and development program, MimiVax is at the forefront of the fight against cancer, striving to bring effective and safe treatments to market.

Algorithm Insights

Market Position
Growing utility with room for optimization
User Engagement
Documented reach suggests active user community
Technical Stack
Modern tech stack aligned with sponsor technologies

Recommendations to Increase Usefulness Score

Document User Growth

Provide specific metrics on user acquisition and retention rates

Showcase Revenue Model

Detail sustainable monetization strategy and current revenue streams

Expand Evidence Base

Include testimonials, case studies, and third-party validation

Technical Roadmap

Share development milestones and feature completion timeline